MoneyWorks4Me

Neuland Laboratories - Quaterly Results

10 Feb 2026 Evaluate
The company witnessed a 10.47% growth in the revenue at Rs. 4397.09 millions for the quarter ended December 2025 as compared to Rs. 3980.32 millions during the year-ago period.A big decline of -60.14% was reported for the quarter ended December 2025 to Rs. 404.17  millions from Rs. 1013.94 millions of corresponding previous quarter.Operating profit for the quarter ended December 2025 decreased to 849.79 millions as compared to 902.82 millions of corresponding quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 4397.09 3980.32 10.47 12467.35 11484.78 8.56 14768.37 15585.80 -5.24
Other Income 80.52 39.06 106.14 177.07 130.45 35.74 205.09 125.44 63.50
PBIDT 849.79 902.82 -5.87 2840.50 2845.89 -0.19 3428.08 4744.65 -27.75
Interest 67.90 22.16 206.41 167.14 59.49 180.95 82.96 139.97 -40.73
PBDT 781.89 1438.44 -45.64 2673.36 3550.44 -24.70 4109.16 4604.68 -10.76
Depreciation 239.17 162.99 46.74 666.43 486.51 36.98 655.42 596.99 9.79
PBT 542.72 1275.45 -57.45 2006.93 3063.93 -34.50 3453.74 4007.69 -13.82
TAX 138.55 261.51 -47.02 501.08 747.00 -32.92 859.48 1011.73 -15.05
Deferred Tax -13.51 12.27 -210.11 -19.77 69.84 -128.31 122.95 15.87 674.73
PAT 404.17 1013.94 -60.14 1505.85 2316.93 -35.01 2594.26 2995.96 -13.41
Equity 129.01 129.01 0.00 129.01 129.01 0.00 129.01 129.01 0.00
PBIDTM(%) 19.33 22.68 -14.80 22.78 24.78 -8.06 23.21 30.44 -23.75
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..